Race and ethnicity and the risk of community-acquired third-generation cephalosporin-resistant uropathogens: a systematic review and meta-analysis
August 7, 2025
Antimicrob Steward Healthc Epidemiol. 2025 Aug 7;5(1):e172.
Management of human babesiosis – approaches and perspectives
Sept 23, 2025
Edouard Vannier, Klaus-Peter Hunfeld, Robert P. Smith & Peter J. Krause
Expert Rev Anti Infect Ther..2025 Sep;23(9):739-752. Epub 2025 Jul 5.
Fighting AntimicroBial Resistance in Carceral Settings (FABRICS) study on antibiotics prescribing in New England prisons
Sept 25, 2025
Antimicrobial Stewardship & Healthcare Epidemiology, Cambridge University Press; September 25, 2025, 5, e235, 1–4
Inter-organizational Relations and Policy Coordination The Quadripartite and Antimicrobial Resistance
Dec 16, 2025
Global Governance: A Review of Multilateralism and International Organizations, 31(4), 428-473.
DOI: 10.1163/19426720-03104001
Language and racial disparities in treatment initiation for patients with pulmonary non-tuberculous mycobacteria
March 1, 2025
Disparities in testing and treatment of pulmonary nontuberculous mycobacteria (P-NTM) warrant further investigation into language and race’s impact on treatment initiation. The objective of the study is to compare the length of treatment initiation for P-NTM patients assessed in the pulmonary and infectious diseases clinics through language and race.
Caution against using plasma mNGS for NHSN CLABSI surveillance
Sept 22, 2025
We read with interest the recent expansion of the National Healthcare Safety Network (NHSN) surveillance criteria to include non-culture-based testing (NCT), including plasma metagenomic next-generation sequencing (mNGS), in bloodstream infection (BSI) definitions. 1 While mNGS provides diagnostic utility in complex cases, Reference MacIntyre, Hirst, Duttagupta, Hollemon, Hong and Blauwkamp2 we have concerns about its integration into healthcare-associated infection (HAI) surveillance frameworks such as NHSN, where standardization, reproducibility, and clinical relevance are essential.
GEODE: an in silico tool that translates in vitro to in vivo predictions of tuberculosis antibiotic combination efficacy
Oct 17, 2025
Maral Budak, Mariana Pereira Moraes, Talia Greenstein, Pauline Maiello , H Jacob Borish, Harris B Chishti, Kara Kracinovsky, Mark Rodgers, Jaime Tomko, Philana Ling Lin, JoAnne L Flynn, Bree B Aldridge, Denise Kirschner
Front Pharmacol. 2025 Oct 17:16:1639673
PMID: 41181601 | PMCID: PMC12575316 | DOI: 10.3389/fphar.2025.1639673
Human Cases of Carbapenemase-Producing Escherichia coli Linked to Spread Between Animals and the Environment in a Veterinary Facility -Massachusetts, USA, 2023
Sept 26, 2025
Ian M DeStefano, Claire L Fellman, Paula M Snippes Vagnone, Melissa A Cumming, Jennifer L Dale, Abbey Ruhland, Jaclyn Dietrich, Catherine M Brown, Esther Fortes, Nicolas N Epie, Amanda Beaudoin, Katherine Janiszewski, Jessica Leaf, Shira Doron, Matthew Doucette, Stephen D Cole
Clin Infect Dis. 2025 Sep 26:ciaf541.
Colistin-resistant Escherichia coli carrying mcr-1 in food, water, hand rinse, and healthy human gut in Bangladesh
January 27, 2020
Publications Publications Keywords Posted by Rima Mycynek 24 Share Copied!
Promises and Challenges of the Type Three Secretion System Injectisome as an Antivirulence Target
February, 2019
Antibiotic resistance is a major public health threat that has stimulated the scientific community to search for nontraditional therapeutic targets. Because virulence, but not the growth, of many Gram-negative bacterial pathogens depends on the multicomponent type three secretion system injectisome (T3SSi), the T3SSi has been an attractive target for identifying small molecules, peptides, and monoclonal antibodies that inhibit its function to render the pathogen avirulent.
- Antibiotic allergy prevalence and documentation quality in Massachusetts long-term care facilities: A cross-sectional surveyJune 17, 2024
- In vitro identification of underutilized β-lactam combinations against methicillin-resistant Staphylococcus aureus bacteremia isolatesJune 25, 2024
- Dipping Your Toe in The CURE Pool: Longitudinal Tracking of Instructors Suggests Use of a Short-Duration CURE Can Catalyze Expansion to Longer CURE ExperiencesJuly 9, 2024
- The impact of 30-day antecedent antibiotic exposure on Clostridioides difficile ribotype patterns and the relationship with clinical outcomes: A single center studyAugust 8, 2024
- Blocking HXA3-mediated neutrophil elastase release during S. pneumoniae lung infection limits pulmonary epithelial barrier disruption and bacteremiaAugust 9, 2024